Enochian Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK INC. | 08/11/2023 | 252.76 K | $143.21 K | -79.48% | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2023 | 251.48 K | $142.49 K | 583.85% | 0.45% |
| VANGUARD GROUP INC | 08/14/2023 | 227.03 K | $128.63 K | -29.55% | 0.40% |
| HOULIHAN FINANCIAL RESOURCE GROUP, LTD. | 08/02/2023 | 201.50 K | $193.00 K | 100.00% | 0.36% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/11/2023 | 155.86 K | $88.31 K | -51.12% | 0.28% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 118.11 K | $66.92 K | 753.85% | 0.21% |
| NATIXIS | 08/11/2023 | 100.00 K | $56.66 K | 67.44% | 0.18% |
| JANE STREET GROUP, LLC | 08/14/2023 | 83.13 K | $47.10 K | 100.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/11/2023 | 56.30 K | $31.90 K | 319.73% | 0.10% |
| STATE STREET CORP | 08/14/2023 | 52.09 K | $29.51 K | -83.06% | 0.09% |
| MORGAN STANLEY | 08/14/2023 | 46.36 K | $26.27 K | -38.70% | 0.08% |
| Y-INTERCEPT (HONG KONG) LTD | 08/14/2023 | 43.22 K | $24.49 K | 100.00% | 0.08% |
| TWO SIGMA ADVISERS, LP | 08/14/2023 | 33.20 K | $18.81 K | -41.13% | 0.06% |
| OLD MISSION CAPITAL LLC | 08/09/2023 | 32.26 K | $18.28 K | 100.00% | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2023 | 31.02 K | $17.58 K | -44.75% | 0.06% |
| DEUTSCHE BANK AG\ | 08/14/2023 | 29.65 K | $16.81 K | -40.29% | 0.05% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2023 | 29.24 K | $16.57 K | 100.00% | 0.05% |
| NORTHERN TRUST CORP | 08/11/2023 | 26.91 K | $15.25 K | -83.55% | 0.05% |
| BLAIR WILLIAM & CO/IL | 08/11/2023 | 26.00 K | $14.73 K | 0.00% | 0.05% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2023 | 12.73 K | $7.22 K | -0.06% | 0.02% |
| CITADEL ADVISORS LLC | 08/14/2023 | 11.90 K | $6.74 K | 100.00% | 0.02% |
| VIRTU FINANCIAL LLC | 07/27/2023 | 11.03 K | $6.00 K | 100.00% | 0.02% |
| BANK OF NEW YORK MELLON CORP | 08/03/2023 | 10.53 K | $5.97 K | -80.86% | 0.02% |
| JPMORGAN CHASE & CO | 08/11/2023 | 7.13 K | $4.04 K | -52.93% | 0.01% |
| RHUMBLINE ADVISERS | 08/08/2023 | 5.52 K | $3.13 K | -81.91% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 08/09/2023 | 3.40 K | $1.92 K | -66.49% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 08/14/2023 | 1.78 K | $1.01 K | -93.86% | 0.00% |
| FMR LLC | 08/11/2023 | 828 | $469 | -80.29% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/15/2023 | 487 | $276 | -85.98% | 0.00% |
| CITIGROUP INC | 08/10/2023 | 3 | $2 | -99.60% | 0.00% |
| GROUP ONE TRADING, L.P. | 08/09/2023 | 1 | $1 | -98.55% | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 08/04/2023 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 09/20/2023 | 0 | $0 | -100.00% | 0.00% |
| LEGAL & GENERAL GROUP PLC | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 08/07/2023 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/10/2023 | 0 | $0 | -100.00% | 0.00% |
| INVESCO LTD. | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| AMALGAMATED BANK | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| AMERITAS INVESTMENT PARTNERS, INC. | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 08/21/2023 | 0 | $0 | -100.00% | 0.00% |
| ALLIANCEBERNSTEIN L.P. | 08/15/2023 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/16/2023 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 07/18/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enochian Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Enochian Biosciences, Inc.. The most heavily invested institutionals were:
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 16,872
3.29% of Enochian Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 16.87 K shares in the last 24 months. This purchase volume represents approximately $11.98 K in transactions.